Cyclobenzaprine hydrochloride and Osteopenia - a phase IV clinical study of FDA data

Summary:

Osteopenia is found among people who take Cyclobenzaprine hydrochloride, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years.

The phase IV clinical study analyzes which people take Cyclobenzaprine hydrochloride and have Osteopenia. It is created by eHealthMe based on reports of 4,834 people who have side effects when taking Cyclobenzaprine hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 03, 2023

4,834 people reported to have side effects when taking Cyclobenzaprine hydrochloride.
Among them, 19 people (0.39%) have Osteopenia.


What is Cyclobenzaprine hydrochloride?

Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 6,554 Cyclobenzaprine hydrochloride users for its effectiveness, alternative drugs and more.

What is Osteopenia?

Osteopenia (a condition where bone mineral density is lower than normal) is found to be associated with 1,986 drugs and 1,129 conditions by eHealthMe.

Number of Cyclobenzaprine hydrochloride and Osteopenia reports submitted per year:

Could Cyclobenzaprine hydrochloride cause Osteopenia?

Time on Cyclobenzaprine hydrochloride when people have Osteopenia *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 100 %
  • 10+ years: 0.0 %

Gender of people who have Osteopenia when taking Cyclobenzaprine hydrochloride *:

  • female: 52.63 %
  • male: 47.37 %

Age of people who have Osteopenia when taking Cyclobenzaprine hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 30.77 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 23.08 %
  • 50-59: 15.38 %
  • 60+: 30.77 %

Common drugs people take besides Cyclobenzaprine hydrochloride *:

  1. Mobic: 10 people, 52.63%
  2. Percocet: 5 people, 26.32%
  3. Gabapentin: 5 people, 26.32%
  4. Dilaudid: 5 people, 26.32%
  5. Ambien: 4 people, 21.05%
  6. Omeprazole: 4 people, 21.05%
  7. Neurontin: 4 people, 21.05%
  8. Zometa: 4 people, 21.05%
  9. Diphenhydramine Hydrochloride: 3 people, 15.79%
  10. Lipitor: 3 people, 15.79%

Common side effects people have besides Osteopenia *:

  1. Pain: 9 people, 47.37%
  2. Constipation: 8 people, 42.11%
  3. Stress And Anxiety: 7 people, 36.84%
  4. Oedema Peripheral (superficial swelling): 7 people, 36.84%
  5. Neck Pain: 7 people, 36.84%
  6. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 7 people, 36.84%
  7. Joint Pain: 7 people, 36.84%
  8. Fall: 7 people, 36.84%
  9. Depression: 7 people, 36.84%
  10. Pain In Extremity: 6 people, 31.58%

Common conditions people have *:

  1. Osteoporosis (bones weak and more likely to break): 4 people, 21.05%
  2. Cystitis Interstitial (unknown cause characterized by bladder pain): 4 people, 21.05%
  3. Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 4 people, 21.05%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 15.79%
  5. Hiv Infection: 3 people, 15.79%
  6. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 15.79%
  7. Depression: 2 people, 10.53%
  8. Pain: 1 person, 5.26%
  9. Neck Pain: 1 person, 5.26%
  10. Stress And Anxiety: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cyclobenzaprine hydrochloride and have Osteopenia?

Check whether Osteopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Osteopenia and when was it recovered:

Expand to all the drugs that have ingredients of cyclobenzaprine hydrochloride:

Alternative drugs to, pros and cons of Cyclobenzaprine hydrochloride:

Common Cyclobenzaprine hydrochloride side effects:

Browse all side effects of Cyclobenzaprine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Osteopenia treatments and more:

COVID vaccines that are related to Osteopenia:

Common drugs associated with Osteopenia:

All the drugs that are associated with Osteopenia:

Common conditions associated with Osteopenia:

All the conditions that are associated with Osteopenia:

How the study uses the data?

The study uses data from the FDA. It is based on cyclobenzaprine hydrochloride (the active ingredients of Cyclobenzaprine hydrochloride) and Cyclobenzaprine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: